The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant ...
CareDx Inc. has entered a strategic collaboration with 10x Genomics to establish ImmuneScape, a multiomics research ...
PLEASANTON, Calif. and PARIS, Nov. 6, 2023 /PRNewswire/ -- OWKIN and 10x Genomics, Inc. (TXG), announce they have entered into an agreement to add 10x Genomics spatial omics and single-cell ...
The 10X Genomics Xenium Analyzer will support true single cell spatial transcriptomics on fresh frozen or fixed tissue samples. You can characterize 100s to 1000s of RNAs in cells and tissues using ...
PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ -- At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc., a leader in single cell and spatial biology, announced a ...
Hosted on MSN
What Is Spatial Transcriptomics?
Spatial transcriptomics is a technique that provides information about gene expression patterns within intact tissues. This technology employs various methodologies, including in situ sequencing (ISS) ...
The "Spatial Genomics and Transcriptomics Market Analysis and Forecast, 2024-2034" report has been added to ResearchAndMarkets.com's offering.
Pleasanton, Calif.-based 10x Genomics, a biotechnology startup developing single-cell and whole genome sequencing technologies, filed a prospectus with the SEC Aug. 19 for an initial public offering ...
Analyst Daniel Brennan of TD Cowen maintained a Hold rating on 10x Genomics (TXG – Research Report), retaining the price target of $18.00. Daniel Brennan has given his Hold rating due to a combination ...
In a report released yesterday, Patrick B Donnelly from Citi maintained a Buy rating on 10x Genomics (TXG – Research Report), with a price target of $23.00. Patrick B Donnelly has given his Buy rating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback